Mirae Asset Global Investments Co., Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 6,251 shares of IRWD stock, worth $9,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,251
Previous 5,499
13.68%
Holding current value
$9,626
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
177Shares Held
159MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$35.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$25 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$24.9 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$24.5 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$12.9 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $236M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...